{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Barik SK"],"funding":["Indian Council of Medical Research, Govt. of India"],"pagination":["898"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7694411"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["20(1)"],"pubmed_abstract":["<h4>Background</h4>Plasma proteins are known to interfere the drug metabolism during therapy. As limited information is available regarding the role of plasma proteins in HIV drug resistance during ART in HIV/AIDS patients, the present study aimed to identify and characterize the differentially expressed plasma proteins in the drug resistant and drug respondent groups of HIV-1 infected patients with > 6 years of first line ART.<h4>Methods</h4>Four-drug resistant (treatment failure) and four-drug respondent (treatment responder) patients were selected for plasma proteomic analysis based on viral load and drug resistance associated mutations from a cohort study designed on the first line ART patients who were enrolled in the antiretroviral therapy center, Sarojini Naidu Medical College, Agra"],"journal":["BMC infectious diseases"],"pubmed_title":["Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy."],"pmcid":["PMC7694411"],"funding_grant_id":["80/990/2015-ECD-I."],"pubmed_authors":["Mohanty KK","Singh TP","Gopal G","Tripathy SP","Barik SK","Jena S","Patil SA","Bisht D","Rawat P","Sharma D","Mohanty AK","Singh R","Tandon R"],"additional_accession":[]},"is_claimable":false,"name":"Identification and differential expression of serotransferrin and apolipoprotein A-I in the plasma of HIV-1 patients treated with first-line antiretroviral therapy.","description":"<h4>Background</h4>Plasma proteins are known to interfere the drug metabolism during therapy. As limited information is available regarding the role of plasma proteins in HIV drug resistance during ART in HIV/AIDS patients, the present study aimed to identify and characterize the differentially expressed plasma proteins in the drug resistant and drug respondent groups of HIV-1 infected patients with > 6 years of first line ART.<h4>Methods</h4>Four-drug resistant (treatment failure) and four-drug respondent (treatment responder) patients were selected for plasma proteomic analysis based on viral load and drug resistance associated mutations from a cohort study designed on the first line ART patients who were enrolled in the antiretroviral therapy center, Sarojini Naidu Medical College, Agra","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Nov","modification":"2026-05-01T00:59:30.87Z","creation":"2021-02-20T03:04:36Z"},"accession":"S-EPMC7694411","cross_references":{"pubmed":["33246440"],"doi":["10.1186/s12879-020-05610-6"]}}